Sarcoma refers to cancerous tumors in the body’s connective tissue and is separated into two main groups – bone sarcomas (tumors in the bone) and soft tissue sarcomas (tumors in the muscle, cartilage, nerves, fat, blood vessels and deep skin tissue). About 15,000 cases of sarcoma are diagnosed in the United States each year.
Our group of orthopedic surgeons at OrthoONE have treated more than 10,000 patients with bone cancer, trauma, infection, bone and soft tissue tumors and other diseases that jeopardize limbs. They provide diagnostic evaluations, second opinions and treatment consultations for a wide range of orthopedic conditions, including:
- Amputations and Amputee Care
- Bone Cancer and Tumors
- Limb Lengthening and Deformity Correction
- Limb and Joint Preservation
- Trauma and Complex Fractures
- Foot and Ankle Deformities
The sarcoma program at Sarah Cannon Cancer Network at Presbyterian/St. Luke's Medical Center (P/SL), is also recognized for its expertise in pediatric and adult extremity tumors. Its multidisciplinary team provides evaluation and treatment for patients with bone or soft tissue tumors.
Surgical treatment options
Several techniques have been pioneered by physicians at P/SL, including:
- Allograft Procedures
- Clinical Research
- Custom Implant Designs
- Foam Metal Technologies
- Growing Prosthesis for Children
- Innovative Amputation Techniques
- Soft Tissue Reconstruction Options
From understanding your diagnosis and coordinating appointments, to learning about clinical trials and transitioning into survivorship, our Sarah Cannon Cancer Network nurse navigators are there for you through every step of the way. Our family of hospitals provides you with convenient access to leading-edge cancer therapies and clinical trials. Through our Sarah Cannon oncology programs, we offer patients personal, individualized care with a trusted network of specialists who address every aspect of cancer care.
Founded as part of the Institute for Limb Preservation (ILP) by Dr. Ross Wilkins and Dr. Tom Arganese in 1986, the sarcoma program at P/SL is recognized for its national expertise in the management of pediatric and adult extremity tumors. Our multidisciplinary team provides expert evaluation and treatment for patients with bone or soft tissue tumors.